Antimicrobial Peptides in Infectious Diseases and Beyond—A Narrative Review

14Citations
Citations of this article
65Readers
Mendeley users who have this article in their library.

Abstract

Despite recent medical research and clinical practice developments, the development of antimicrobial resistance (AMR) significantly limits therapeutics for infectious diseases. Thus, novel treatments for infectious diseases, especially in this era of increasing AMR, are urgently needed. There is ongoing research on non-classical therapies for infectious diseases utilizing alternative antimicrobial mechanisms to fight pathogens, such as bacteriophages or antimicrobial peptides (AMPs). AMPs are evolutionarily conserved molecules naturally produced by several organisms, such as plants, insects, marine organisms, and mammals, aiming to protect the host by fighting pathogenic microorganisms. There is ongoing research regarding developing AMPs for clinical use in infectious diseases. Moreover, AMPs have several other non-medical applications in the food industry, such as preservatives, animal husbandry, plant protection, and aquaculture. This review focuses on AMPs, their origins, biology, structure, mechanisms of action, non-medical applications, and clinical applications in infectious diseases.

Cite

CITATION STYLE

APA

Ioannou, P., Baliou, S., & Kofteridis, D. P. (2023, August 1). Antimicrobial Peptides in Infectious Diseases and Beyond—A Narrative Review. Life. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/life13081651

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free